https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
Avient corporation first quarter 2023 results
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
F E B R U A R Y 2 0 2 4
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
AS HIS H KHANDP UR
P R E S I D E N T & C E O
7
8
PORTFOLIO TRANSFORMATION
8
7%
46%
66%
87%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2020 2023
%
o
f A
dj
us
te
d
E
B
IT
D
A
Commodity JVs Distribution Performance Products & Solutions Specialty Businesses
Adjusted EBITDA from Specialty Applications
SUSTAINABILITY AS A GROWTH DRIVER
9
LONG-TERM REVENUE GROWTH DRIVERS
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
60%+
Key Growth
Drivers
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other 0–2%
Avient 6%
END MARKET OBSERVATIONS
( % O F C O M PA N Y S A L E S )
ENERGY
5%
DEFENSE
7%
TELECOMMUNICATIONS
4%
HEALTHCARE
7%
10
TRANSPORTATION
10%
INDUSTRIAL
16%
BUILDING &
CONSTRUCTION 9%
CONSUMER
19%
PACKAGING
23%
11
REGIONAL OBSERVATIONS
( % O F C O M PA N Y S A L E S )
11
US & Canada
Latin America
EMEA
Asia
41%
36%
18%
5%
Q 4 2 0 2 3 R E S U L T S
Q4 2023 PERFORMANCE VS.
PY
( T O TA L C O M PA N Y )
$790
$719
2022 2023
$107
$114
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.52
2022 2023
Adjusted EPS
(in millions)
- 9% + 7% + 24%
Sales Adjusted EBITDA Adjusted EPS
15
Q4 2023 SEGMENT PERFORMANCE
16
CAI
$491
$459
Sales
(in millions)
$70
$84
EBITDA
SEM
$301
$260
Sales
$55
$49
EBITDA
- 7% - 14%+20% - 11%
2022 2023
(in millions)
Q4 EBITDA BRIDGE
( T O TA L C O M PA N Y )
17
$ millions
CAI:
Price / Mix 11
Deflation 14
SEM:
Price / Mix 4
Deflation 9
Net Price Benefit 38
Cost Reductions 13
Wage Inflation (8)
Other (2)
Q4 2023 $114
Adjusted
EBITDA
Q4 2022 $ 107
Demand (34) • Demand was down, but less than in previous
quarters, due to slowing pace of destocking
• Positive net price benefit:
o CAI – Pricing flat with favorable mix from
uptick in packaging and consumer end
markets and raw material deflation
o SEM - Pricing flat with favorable mix from
Composites and raw material deflation
• Cost reductions primarily driven by reduced
administrative costs and cost synergies
2 0 2 4 G U I D A N C E
2024 GUIDANCE
Full Year 2024 Guidance
Adjusted EBITDA $505 to $535 million
Adjusted EPS $2.40 to $2.65
Interest Expense $105 to $110 million
Adjusted Effective Tax Rate 23% to 25%
Capital Expenditures ~$140 million
19
Q1 Adjusted EPS of $0.68
A P P E N D I X
21
Performance
Additives
15%
Pigments
13%
TiO2
9%
Dyestuffs
2%
Polyethylene
10%Nylon
5%
Polypropylene
4%
Styrenic Block
Copolymer
4%
Other Raw
Materials
38%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
RA W MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
41%
EMEA
36%
Asia
18%
Latin America
5%
2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
19%
Packaging
23%Industrial
16%
Building and
Construction
9%
Telecommunications
4%
Energy
5%
Defense
7%
END MARKET REVENUE
$2,007M $358M
$1,138M $224M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$502M$3,143M
(1)
Transportation
10%
Healthcare
7%
23
(1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N
US & Canada
34%
EMEA
37%
Asia
21%
Latin America
8%
END MARKET REGION
24
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
9%
Building &
Construction
10%
Telecommunications
1% Energy
2%
COLOR, ADDITIVES & INKS
2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
25
Packaging
5%
Consumer
16%
Healthcare
6%Industrial
16%
Transportation
12%
Telecommunications
9%
Energy
10% Defense
18%
Building &
Construction
8%
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
Packaging
32%
Consumer
26%
Healthcare
9%
Industrial
13%
Building &
Construction
6%
Telecommunications
2%
Energy
2% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 3 AV I E N T R E G I O N A L S A L E S
Packaging
25%
Consumer
13%
Healthcare
5%
Industrial
18%
Building &
Construction
9%
Energy
5%
Defense
8%
EMEA
(36% of sales)Transportation
13%
Packaging
13%
Consumer
22%
Healthcare
10%
Industrial
16%
Building &
Construction
12%
Energy
6%
Defense
8%
US &
Canada
(41% of sales)
Transportation
9%
Packaging
59%
Consumer
22%
Healthcare
2%
Industrial
8%
Building &
Construction
4%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
4%
Telecommunications
4%
26
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
Avient corporation first quarter 2023 results
AVIENT CORPORATION
I N V E S T O R P R E S E N T A T I O N
(NYSE: AVNT)
J A N U A R Y 2 0 2 4
D I S C L A I M E R
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
GUIDANCE
$800
$754
Guidance Actual
$128
$123
Guidance Actual
Sales Adjusted EBITDA
(in millions)
$0.56 $0.57
Guidance Actual
Adjusted EPS
(in millions)
13
• Demand impacted by destocking
and cautious customer sentiment
• Positive net price benefit:
o CAI - Pricing flat and raw
material deflation
o SEM - Pricing flat with
unfavorable mix related to
healthcare, more than offset
with raw material deflation
• Cost reductions driven by Clariant
synergies and reduced
administrative costs
Q3 EBITDA BRIDGE
($ millions)
CAI:
Price / Mix -)
Deflation 22)
SEM:
Price / Mix (6)
Deflation 13)
Net Price Benefit 29)
Cost Reductions 13)
Wage Inflation (8)
FX 1)
Q3 2023 Actual $ 123)
Adjusted
EBITDA
Q3 2022 Pro Forma $ 137)
Demand (49)
14
2 0 2 3 G U I D A N C E
Q4 2023 GUIDANCE VS.
PRIOR YEAR
$790
$710
2022 2023
$107
$112
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.47
2022 PF 2023
Adjusted EPS
(in millions)
- 10% + 5% + 12%
Sales Adjusted EBITDA Adjusted EPS
16
$112
$500
Q4 FY
$0.47
$2.30
Q4 FY
Q4 AND FULL YEAR 2023 GUIDANCE
$710
$3,130
Q4 FY
Sales Adjusted EBITDA Adjusted EPS
17
(in millions) (in millions)
Guidance: Free Cash Flow
$180 $180
Prior Guidance Guidance
FREE CASH FLOW & INCREASED DIVIDEND
13th Consecutive Dividend Increase
0.16
0.26
0.42
0.58
0.79
0.85
0.99
1.03
2011 2013 2015 2017 2019 2021 2023 2024
18
S U S T A I N A B I L I T Y D AY
R E C A P
SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS
60%+
Key Growth
Drivers
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
(GDP Growth)
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other (GDP growth) 0–2%
Avient 6%
20
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
8-12%
Long Term
Growth
50
90
2022 2030
Medical Plastics
Market Size
(in $Billions)
2020 2030
Recycled
Plastics
Virgin
Plastics
Growing Demand
for Recycled
Content
Avient Sustainable
Solutions
18
46
2023 2032
Global Offshore Annual
Wind Installations
(in Gigawatts)
Sources: McKinsey, Bloomberg, Grand View Research
SUSTAINABILITY TRENDS DRIVE
LONG-TERM GROWTH
21
• Transformative acquisitions
combined with divestitures of
more cyclical businesses have
improved margins over 400 bps
since 2018
• 20% long-term margin goal to
be driven by key growth drivers,
with sustainable solutions
playing a meaningful role
5.4%
11.5%
16.0%
2006 2018 2023E Recovery Growth
Drivers
Strategic
Objective
20%+
+1%+
+3%+
ADJUSTED EBITDA MARGIN EXPANSION
22
• 6% annualized long-term sales growth leveraging
sustainable solutions, composites, healthcare, and
emerging regions
• Expand EBITDA margins to 20%
• Deliver annual EBITDA and EPS growth of
10% and 15%
• Maintain asset-light, 80% free cash flow conversion
profile and be valued as a specialty formulator
• Continue fostering our Great Place to Work® culture
CRE AT ING A WORL D-CL AS S
S US TAINABL E ORGANIZ AT ION
23
PEER COMPARISONS
AVIENT IS ASSET LIGHT
Capex / Revenue
2023E (%)
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
Source: Peer data per Bloomberg as of December 29, 2023
Note: Avient reflects 2023 estimated revenue of $3,130 and estimated run-rate CAPEX of $110M.
26
3.5
1.8
2.7
3.1 3.3
3.7
3.0
3.7
4.7 4.8
6.8 6.8
8.7
11.1
A
vi
en
t
K
W
R
FU
L
P
P
G
A
V
Y
R
P
M
FM
C
H
U
N
C
E
E
C
L
H
X
L
A
S
H
E
M
N
S
C
L
FREE CASH FLOW CONVERSION
Source: Peer data per Bloomberg as of December 29, 2023
Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA.
https://www.avient.com/sites/default/files/resources/PDI_Healthcare_Brochure_2011_0.pdf
HC_Industry bulletin_PDI_final.indd
www.polymerdiagnostics.com
I n d u s t r y B u l l e t i n
Polymer Diagnostics Inc.
Benefi ts:
As a result of side-by-side R&D and laboratory work, the two companies ultimately
optimized a proprietary method for bonding the polymer disc and titanium plates.
Benefi ts:
As a result of side-by-side R&D and laboratory work, the two companies ultimately
optimized a proprietary method for bonding the polymer disc and titanium plates.
https://www.avient.com/sites/default/files/2021-08/avient-cdp-climate-change-questionnaire-2021.pdf
As such, the annual cost of response is Avient’s 2020
R&D spend $59.8 million * 1 year = $59,800,000.
As such, the annual cost of response is Avient’s 2020
R&D spend $59.8 million * 1 year = $59,800,000.
We implemented a Sustainability
Scorecard that improved R&D focus on sustainability.
https://www.avient.com/sites/default/files/2023-03/Fiber-Line Global Product Selection Guide.pdf
FIBER-LINE™
High Performance
Synthetic Fibers
PRODUCT SELECTION GUIDE
FIBER-LINE™ HIGH PERFORMANCE SYNTHETIC FIBERS
Kevlar® Para-Aramid
Nomex®
Meta-Aramid
Vectran® LCP Zylon® PBO
Carbon
Fiber
UHMWPE PET Polyester Fiberglass Novoloid
Technora®
Filament Yarn
TECHNICAL PROPERTIES Standard Modulus
High
Modulus
Standard
Modulus
Standard
Modulus
High
Modulus
Standard
Modulus
High
Modulus
Standard
Modulus
Standard
Modulus
High
Modulus
High
Tenacity
Low
Shrink
E-Glass S-Glass
Standard
Modulus
Standard
Modulus
Breaking Tenacity (g/d) 23.0 23.6 5.0 23.0 30.0 42.0 42.0 23.0 28.0 38 9.3 8.4 6.0 - 7.3 6.7 - 9.4 1.5 28.0
Specific Gravity (Ratio) 1.44 1.44 1.38 1.40 1.40 1.54 1.56 1.80 0.97 0.97 1.38 1.38 2.58 2.48 1.27 1.39
Elongation at Break (%) 3.5 2.5 30.0 3.8 2.8 3.5 2.5 1.5 3.5 3.1 14.6 19.5 3.5 5.5 30.0 - 40.0 4.6
Tensile Modulus (g/d) 555 885 125 600 830 1200 1800 1480 850 1250 120 70 200–275 140–170 2.5–5.0 590
Equilibrium Moisture Regain
at 55% RH (%)
5.0 5.0 4.5
https://www.avient.com/sites/default/files/2022-06/Trendwatch Overcoming 5G Component Challenges eBook_CN.pdf
PowerPoint 演示文稿
目录
简介
基本原理
R +
D
$23 亿美元
5G技术要求
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
新一代速度 + 性能
经IDTechEx授权发布。
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_ITA2.pdf
D&R
D: ho visto in azienda qualcosa che sembrava violare il Codice.
D&R
D: mi è stato chiesto di fare dei viaggi di lavoro.
D&R
D: Lavoro nel reparto Approvvigionamento.
https://www.avient.com/sites/default/files/2024-07/TPE Whitepaper_0.pdf
Parts Cost
Surplus Stock
Carbon Footprint
Power Consumption
Production Time
TPE Benefits
TPEs can reduce:
TPE Applications
TPEs can used to produce:
Better grips on
instruments
Easy
branding
Easy-to-open
pill bottles
Needs to Meet Future Growth
2010
TPE
Substrate
2030
Futu
re De
man
d
2050
Supply Chain Cap
acity
TPE
Substrate
Parts Cost
Surplus Stock
Carbon Footprint
Power Consumption
Production Time
TPE Benefits
TPEs can reduce:
TPE Applications
TPEs can used to produce:
Better grips on
instruments
Easy
branding
Easy-to-open
pill bottles
Needs to Meet Future Growth
2010
TPE
Substrate
2030
Futu
re De
man
d
2050
Supply Chain Cap
acity
TPE
Substrate
3© 2020 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012
3.
Parts Cost
Surplus Stock
Carbon Footprint
Power Consumption
Production Time
TPE Benefits
TPEs can reduce:
TPE Applications
TPEs can used to produce:
Better grips on
instruments
Easy
branding
Easy-to-open
pill bottles
Needs to Meet Future Growth
2010
TPE
Substrate
2030
Futu
re De
man
d
2050
Supply Chain Cap
acity
TPE
Substrate
4© 2020 Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012
CASE IN POINT: STOPPERS AND SEPTUMS
Versaflex™ HC TPE from Avient offers customers an exceptional
alternative to rubber for septums and stoppers.
https://www.avient.com/sites/default/files/2022-10/PREPERM_for_5G_Application_Bulletin_CN10.8-2.pdf
在很宽的频率范围仍保持稳定的射频性能
0 ,0
2 ,0
4 ,0
6 ,0
8 ,0
1 0 ,0
1 2 ,0
0 1 0 2 0 3 0 4 0 5 0 6 0
D
ie
le
ct
ri
c
co
n
s
ta
n
t
F re que nc y [G H z ]
P R E P E R M ® P P E 95 0 P R E P E R M ® P P E 80 0
P R E P E R M ® P P E 44 0 P R E P E R M ® P P E 32 0
P R E P E R M ® P P E 26 0
生产过程中批次间的稳定性
* 2018 年芬兰有限公司VTT技术研究中心测量数据
介
电
常
数
损
耗
因
数
介
电
常
数
频率 [GHz]
频率 [GHz]
分批编号 (1250 kg/批次)
PREPERM™ PPE950
PREPERM™ PPE800
PREPERM™ PPE440
PREPERM™ PPE320
PREPERM™ PPE260
-- 目标介电常数
-- +/- 2%
3 ,7 6
3 ,7 8
3 ,8 0
3 ,8 2
3 ,8 4
3 ,8 6
3 ,8 8
3 ,9 0
3 ,9 2
3 ,9 4
0 1 2 3 4 5 6 7 8
D
ie
le
ct
ri
c
co
n
s
ta
n
t
P a lle t numbe r (1 2 5 0 k g/pa lle t )
D ie le c t ric c o n s t a nt t a rge t +/ - 2 %
0 ,0 0 0
0 ,0 0 2
0 ,0 0 4
0 ,0 0 6
0 ,0 0 8
0 ,0 1 0
0 1 0 2 0 3 0 4 0 5 0 6 0
L
o
s
s
t
a
n
g
e
n
t
F re que nc y [G H z ]
P R E P E R M ® P P E 95 0 P R E P E R M ® P P E 80 0
P R E P E R M ® P P E 44 0 P R E P E R M ® P P E 32 0
P R E P E R M ® P P E 26 0
0 ,0 0 0
0 ,0 0 2
0 ,0 0 4
0 ,0 0 6
0 ,0 0 8
0 ,0 1 0
0 1 0 2 0 3 0 4 0 5 0 6 0
L
o
s
s
t
a
n
g
e
n
t
F re que nc y [G H z ]
P R E P E R M ® P P E 95 0 P R E P E R M ® P P E 80 0
P R E P E R M ® P P E 44 0 P R E P E R M ® P P E 32 0
P R E P E R M ® P P E 26 0
0 ,0 0 0
0 ,0 0 2
0 ,0 0 4
0 ,0 0 6
0 ,0 0 8
0 ,0 1 0
0 1 0 2 0 3 0 4 0 5 0 6 0
L
o
s
s
t
a
n
g
e
n
t
F re que nc y [G H z ]
P R E P E R M ® P P E 95 0 P R E P E R M ® P P E 80 0
P R E P E R M ® P P E 44 0 P R E P E R M ® P P E 32 0
P R E P E R M ® P P E 26 0
1.844.4AVIENT
www.avient.com
版权所有©2022 埃万特公司。
https://www.avient.com/sites/default/files/2022-09/Avient Pro Forma Financial Information.pdf
AVIENT CORPORATION
P R O F O R M A F I N A N C I A L S F O R D Y N E E M A
A C Q U I S I T I O N A N D D I S T R I B U T I O N A S
D I S C O N T I N U E D O P E R A T I O N S
(NYSE: AVNT)
S E P T E M B E R 2 7 , 2 0 2 2
DISCLAIMER
Forward-Looking Statements
Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.